Bioceltix S.A. (BCX.WA)

PLN 126.8

(2.26%)

Revenue Summary of Bioceltix S.A.

  • Bioceltix S.A.'s latest annual revenue in 2023 was - PLN , down 0.0% from previous year.
  • Bioceltix S.A.'s latest quarterly revenue in 2024 Q2 was - PLN , down 0.0% from previous quarter.
  • Bioceltix S.A. reported a annual revenue of - PLN in annual revenue 2022, down 0.0% from previous year.
  • Bioceltix S.A. reported a annual revenue of - PLN in annual revenue 2021, down -100.0% from previous year.
  • Bioceltix S.A. reported a quarterly revenue of - PLN for 2024 Q2, down 0.0% from previous quarter.
  • Bioceltix S.A. reported a quarterly revenue of - PLN for 2023 FY, down 0.0% from previous quarter.

Annual Revenue Chart of Bioceltix S.A. (2023 - 2018)

Created with Highcharts 11.1.0YearsRevenue20182018.520192019.520202020.520212021.520222022.520230 PLN2500 PLN5000 PLN7500 PLN10000 PLN12500 PLN

Historical Annual Revenue of Bioceltix S.A. (2023 - 2018)

Year Revenue Revenue Growth
2023 - PLN 0.0%
2022 - PLN 0.0%
2021 - PLN -100.0%
2020 10.8 Thousand PLN 620.0%
2019 1500.00 PLN -83.7%
2018 9202.40 PLN 0.0%

Peer Revenue Comparison of Bioceltix S.A.

Name Revenue Revenue Difference
BIOTON S.A. 181.63 Million PLN 100.0%
Captor Therapeutics Spolka Akcyjna 13.2 Million PLN 100.0%
Mabion S.A. 151.67 Million PLN 100.0%
Molecure S.A. 100.00 PLN 100.0%
NanoGroup S.A. 2019.00 PLN 100.0%
Pharmena S.A. 9.83 Million PLN 100.0%
Poltreg S.A. 1.39 Million PLN 100.0%
Pure Biologics Spólka Akcyjna 95 Thousand PLN 100.0%
Ryvu Therapeutics S.A. 46.86 Million PLN 100.0%
Synthaverse S.A. 58.6 Million PLN 100.0%
Urteste S.A. - PLN NaN%